Benitec Biopharma Ltd (BNTC): Great news regarding Calimmune fDA Ap...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	138
Posts	22894
Boards Moderated	0
Alias Born	04/08/2004

georgejjl

Re: None

Friday, 03/20/2015 8:24:29 PM

Friday, March 20, 2015 8:24:29 PM

Great news regarding Calimmune

fDA Approves Further Study Of Promising Gene Therapy HIV Treatment

http://touch.towleroad.com/all/2015-03-fda-approves-promising-gene-therapy-hiv-treatment.html#1

Good luck and GOD bless,

George

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent BNTC News

Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:17:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:13:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:12:19 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/06/2024 05:15:18 AM
Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 02/26/2024 02:06:56 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/23/2024 09:09:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 01:01:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:15:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 12:31:00 PM
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/17/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:03:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:49 PM
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/20/2023 08:31:26 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2023 10:04:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 09:19:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 12:05:29 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/21/2023 12:00:53 PM
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 09:26:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:01:00 PM
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/11/2023 05:00:12 PM

More BNTC News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover